The Lancet Diabetes & Endocrinology Commission on type 1 diabetes: From research to policy: still a long way to go

Critical issues in diabetes and endocrinology research include the prevalence of research waste and the lack of impact from transformative studies that fail to reach policymakers. Many medical studies are poorly designed or reported, which limits their clinical and public health relevance. Even high-quality research, such as systematic reviews, can be misleading when based on flawed data. Despite efforts to improve research transparency, the translation of research into policy remains limited, particularly for conditions like diabetes, which are often deprioritized by policymakers. This article highlights the need for stronger engagement between researchers and policymakers, as well as greater accessibility of research findings to ensure their influence on health policies.